BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31023275)

  • 1. Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications.
    Kelddal S; Nykjær KM; Gregersen JW; Birn H
    BMC Nephrol; 2019 Apr; 20(1):139. PubMed ID: 31023275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study.
    Welander F; Holmberg H; Dimény E; Jansson U; Själander A
    PLoS One; 2021; 16(7):e0255009. PubMed ID: 34319998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases.
    Kelddal S; Hvas AM; Grove EL; Birn H
    BMC Nephrol; 2022 Sep; 23(1):305. PubMed ID: 36064370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.
    Medjeral-Thomas N; Ziaj S; Condon M; Galliford J; Levy J; Cairns T; Griffith M
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):478-83. PubMed ID: 24334865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.
    Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R
    Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding.
    Eijgenraam P; ten Cate H; ten Cate-Hoek AJ
    Neth J Med; 2014 Apr; 72(3):157-64. PubMed ID: 24846933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum.
    Glassock RJ
    J Am Soc Nephrol; 2007 Aug; 18(8):2221-5. PubMed ID: 17599972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
    Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
    Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic prophylaxis protocol with warfarin after radiofrequency catheter ablation of infarct-related ventricular tachycardia.
    Siontis KC; Jamé S; Sharaf Dabbagh G; Latchamsetty R; Jongnarangsin K; Morady F; Bogun FM
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):584-590. PubMed ID: 29315941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of prophylactic anticoagulation in patients with primary nephrotic syndrome: a systematic review and meta-analysis.
    De Pascali F; Brunini F; Rombolà G; Squizzato A
    Intern Med J; 2024 Feb; 54(2):214-223. PubMed ID: 37713623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.